Skip to main content

Table 1 Basic clinical information for the four cohorts

From: A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts

Clinical factors TCGA_BLCA GSE13507 GSE32548 GSE32894
n = 403 % n = 165 % n = 130 % n = 224 %
Age
 60 107 26.55 46 27.88 27 20.77 46 20.54
 > 60 296 73.45 119 72.12 103 79.23 178 79.46
Gender
 Male 298 73.95 135 81.82 99 76.15 163 72.77
 Female 105 26.05 30 18.18 31 23.85 61 27.23
T stage
 < T2 4 0.99 104 63.03 91 70 173 77.23
 T2 366 94.29 61 36.97 38 29.23 51 22.77
Grade (WHO2004)
 Low 20 4.96 105 63.64
 High 380 94.29 60 36.36
Grade (WHO1999)
 G1 15 11.54 45 20.09
 G2 40 30.77 84 37.50
 G3 75 57.69 93 41.52
Vital status
 Alive 248 61.54 96 58.18 105 80.77 199 88.84
 Dead 155 38.46 69 41.82 25 19.23 25 11.16
Follow-up (mean ± SD, year)
  2.10 ± 2.23 3.98 ± 3.10 4.14 ± 2.38 3.28 ± 2.10
  1. SD standard deviation